A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/435 (2006.01) A61K 31/425 (2006.01) A61K 31/428 (2006.01) A61K 31/437 (2006.01) A61K 31/44 (2006.01) A61K 31/48 (2006.01)
Patent
CA 2327299
This invention discloses new uses and treatments involving cabergoline, pramipexole and new combinations of cabergoline plus pramipexole used to treat patients. Here we disclose the use of cabergoline or pramipexole to treat PSP and MSA. Also disclosed is a combination treatment of cabergoline and pramipexole provided concurrently to a patient in need thereof for the treatment of various central nervous system diseases and in particular for the treatment of Parkinson's Disease (PD), but also for PSP and MSA.
Cette invention porte sur de nouvelles utilisations et de nouveaux traitements dans lesquels sont impliqués la cabergoline, le pramipexole et de nouvelles combinaisons de ceux-ci utilisées pour traiter des patients. L'invention porte notamment sur l'utilisation de la cabergoline ou du pramipexole pour traiter la paralysie supranucléaire évolutive (PSP) et l'atrophie multisystémique (MSA). L'invention porte également sur un traitement d'association de la cabergoline et du pramipexole appliqués simultanément à des patients atteints de diverses maladies du système nerveux central et notamment de la maladie de Parkinson, mais également de la PSP et la MSA.
Macrae & Co.
Pharmacia & Upjohn Company
LandOfFree
Cabergoline and pramipexole for treating cns diseases,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cabergoline and pramipexole for treating cns diseases,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cabergoline and pramipexole for treating cns diseases,... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1607708